T Itoshima
Overview
Explore the profile of T Itoshima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakatou T, Nakata K, Nakamura A, Itoshima T
Diabet Med
. 2004 Mar;
21(3):223-9.
PMID: 15008831
Aims: The purpose of this study was to investigate the usefulness of carotid haemodynamic parameters, i.e. the resistive index (RI) and the pulsatility index (PI), in estimating the risk of...
2.
Kojima K, Fujii N, Omoto E, Nose S, Yoneyama M, Sugii Y, et al.
Ann Hematol
. 2003 Feb;
82(1):61-3.
PMID: 12574969
A periodic fall of platelet number characterizes an acquired pathological condition named cyclic thrombocytopenia. We describe an unusual case of polycythemia vera in which the episodes of thrombocytopenia were followed...
3.
Kojima K, Fujii N, Takata S, Tezen T, Morikawa T, Kaneda K, et al.
Ann Hematol
. 2002 Jul;
81(6):350-1.
PMID: 12107569
A 67-year-old woman with previously untreated essential thrombocythemia developed bilateral adrenal hemorrhage. She had no known vascular risk factors including smoking, diabetes mellitus, hypertension, and hypercholesterolemia. Her platelet count was...
4.
Fukazawa T, Fujiwara T, Uno F, Teraishi F, Kadowaki Y, Itoshima T, et al.
Oncogene
. 2001 Aug;
20(37):5225-31.
PMID: 11526513
Apoptosis is a morphologically distinct form of programmed cell death that plays a major role in cancer treatments. This cellular suicide program is known to be regulated by many different...
5.
Waku T, Fujiwara T, Shao J, Itoshima T, Murakami T, Kataoka M, et al.
J Immunol
. 2000 Nov;
165(10):5884-90.
PMID: 11067949
Clinical trials of adenoviral p53 gene therapy provide the evidence that the bystander effect induced by the wild-type p53 gene transfer on adjacent tumor cells contributes to tumor progression; its...
6.
Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough W, et al.
Clin Cancer Res
. 2000 Jul;
6(7):2851-9.
PMID: 10914734
Transcriptional factor E2F-1 as well as tumor suppressor p53 have been shown to cause apoptosis independently in some types of human cancer cells when overexpressed. Here we report that sequential...
7.
Shao J, Fujiwara T, Kadowaki Y, Fukazawa T, Waku T, Itoshima T, et al.
Oncogene
. 2000 Mar;
19(6):726-36.
PMID: 10698490
The tumor suppressor gene p53 is a potent transcriptional regulator of genes which are involved in many cellular activities including cell cycle arrest, apoptosis, and angiogenesis. Recent studies have demonstrated...
8.
Kadowaki Y, Fujiwara T, Fukazawa T, Shao J, Yasuda T, Itoshima T, et al.
Clin Cancer Res
. 2000 Jan;
5(12):4233-41.
PMID: 10632365
When keratinocytes withdraw from the cell cycle, they migrate from the basal to the superficial layers of the epidermis and undergo morphological and biochemical changes during the process of terminal...
9.
Itoshima T, Yamamoto T, Kasamatsu T, Fujino H, Yamamoto H, Morita Y, et al.
Gan To Kagaku Ryoho
. 1997 Aug;
24(10):1331-3.
PMID: 9279355
A case of breast cancer metastasis to the skin and bone 13 years after, and to the brain 17 years after mastectomy in a 54-year-old woman, is reported. In 1978,...
10.
Nonaka M, Oosawa J, Nakanishi M, Kamiyama J, Idoguchi K, Tabata T, et al.
Gan To Kagaku Ryoho
. 1996 Sep;
23(11):1568-70.
PMID: 8854807
A 68-year-old male diagnosed as Borrmann 2 type gastric cancer (T3N3P3H0M0: Stage IVb) was treated by distal gastrectomy and administration of CDDP 50 mg+MMC 10 mg intraperitoneally. After operation intraperitoneal...